4//SEC Filing
Cahill Brian Joseph 4
Accession 0001209191-24-001256
CIK 0000827871other
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 5:01 PM ET
Size
5.1 KB
Accession
0001209191-24-001256
Insider Transaction Report
Form 4
Cahill Brian Joseph
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2024-01-05$5.13/sh−735$3,771→ 46,681 total
Footnotes (1)
- [F1]The disposition reported on this Form 4 represents shares withheld by the Issuer to cover the tax liability upon the vesting of time-based restricted stock units previously granted and does not represent a discretionary transaction by the Reporting Person.
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeother
Related Parties
1- filerCIK 0001831591
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 5:01 PM ET
- Size
- 5.1 KB